Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,521,649
-
Share change
-
+3,505,202
-
Total reported value
-
$1,386,919,202
-
Price per share
-
$52.29
-
Number of holders
-
115
-
Value change
-
+$184,962,632
-
Number of buys
-
77
-
Number of sells
-
34
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q3 2018
As of 30 Sep 2018,
G1 THERAPEUTICS INC - COM (GTHX) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,521,649 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Vanguard Group Inc, Bank of New York Mellon Corp, Capital World Investors, FRANKLIN RESOURCES INC, Hillhouse Capital Management, Ltd., and STATE STREET CORP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.